Author:
Machaczka Maciej,Kämpe Björkvall Cecilia,Wieremiejczyk Joanna,Paucar Arce Martin,Myhr-Eriksson Kristina,Klimkowska Monika,Hägglund Hans,Svenningsson Per
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Reference19 articles.
1. Czartoryska B, Tylki-Szymańska A, Ługowska A (2000) Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease. Clin Biochem 33:147–149
2. Dahl N, Lagerström M, Erikson A et al (1990) Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet 47:275–278
3. Davies EH, Mengel E, Tylki-Szymańska A et al (2011) Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool. J Inherit Metab Dis 34:1053–1059
4. Deroma L, Sechi A, Dardis A et al (2013) Did the temporary shortage in supply of imiglucerase have clinical consequences? Retrospective observational study of 34 Italian Gaucher type I patients. JIMD Rep 7:117–122
5. Dreborg S, Erikson A, Hagberg B (1980) Gaucher disease—Norrbottnian type. General clinical description. Eur J Pediatr 133:107–118
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献